Anges to Repurchase 35M-70M Yuan Shares with IPO Overfunds
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Anges (安杰思) announced that its actual controller, chairman and general manager Zhang Cheng proposed on September 22, 2026, that the company repurchase its own shares using over-raised funds from its initial public offering (IPO) of RMB ordinary shares. The total buyback amount is set at no less than RMB 35 million and no more than RMB 70 million. The repurchase price will not exceed 150% of the average trading price of the company's shares in the 30 trading days before the board considers the buyback plan. The repurchased shares are intended for use in an employee stock ownership plan or equity incentive plan. The proposal is subject to board approval.
Source report
Shanghai, China — Anges (安杰思) announced that Mr. Zhang Cheng, the company's actual controller, Chairman, and General Manager, proposed on September 22, 2026, that the company repurchase its shares using excess funds raised from its initial public offering (IPO) of Renminbi-denominated ordinary shares.
Key Details of the Buyback Proposal
- Total Buyback Amount: No less than RMB 35 million (inclusive) and no more than RMB 70 million (inclusive)
- Buyback Price Cap: No higher than 150% of the average trading price of the company's shares during the 30 trading days prior to the board's review and approval of the share buyback plan
- Purpose of Buyback: The repurchased shares will be used for employee stock ownership plans or equity incentive plans
The proposal is subject to board approval and relevant regulatory procedures.
Source
证券之星-股市直击Neutral / independent
Part of this Story
Anges Medical Chairman Proposes 35-70 Million Yuan Share Buyback Using IPO Funds